Remote Electrical Stimulation for Pain and Depression Treatment in Cirrhosis
Active, not recruitingNot applicableNCT06932783
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study is being done to better understand how the study team can treat pain for people with cirrhosis and depression. Enrolled participants on this feasibility study will be randomized to Transcutaneous Electrical Acustimulation (TEA) or sham TEA.
Study details
- Official title
- RESTORE: Remote Electrical Stimulation for Pain and Depression Treatment in Cirrhosis
- Conditions
- Cirrhosis
- Interventions
- Device: Transcutaneous Electrical Acustimulation (TEA)
- Device: Sham Transcutaneous Electrical Acustimulation (TEA)
- Sponsor
- University of Michigan
- Start date
- 2025-07-22
- Primary completion
- 2027-07
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Diagnosis of cirrhosis - must meet the criteria as outlined in the protocol * Chronic pain (Patient self-reports ≥ 4 on the 0-10 scale for \>50% of days within 3- months) * Depression (in at least half of participants) - must meet the criteria as outlined in the protocol * English speaking * Willing to use a Transcutaneous Electrical Acustimulation device Exclusion Criteria: * Dementia and/or severe cognitive impairment * Unable or unwilling to provide consent * Expected to undergo liver transplant in next 24 weeks * No email address * Deemed unsuitable by the study investigator
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06932783